Laurel for start-up for proposal on fighting AMR

Vividew Innovations Private Limited, a start-up incubated at the Business Innovation and Incubation Centre (BIIC) of Mahatma Gandhi University, has earned national recognition for its approach to combating antimicrobial resistance (AMR). The company's proposal was selected by the Centre for Cellular and Molecular Platforms (C-CAMP) in the AMR challenge as one of nine solutions from nearly 200 submissions across India.
Vividew's solution focusses on eliminating antibiotics and antibiotic-resistant bacteria from hospital wastewater. It employs an integrated treatment process combining advanced oxidation, membrane filtration, biological treatment, and thermal processing. The system is noted for being cost-effective, scalable and well-suited for implementation in healthcare environments.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

The Hindu

a day ago

• The Hindu

Laurel for start-up for proposal on fighting AMR

Vividew Innovations Private Limited, a start-up incubated at the Business Innovation and Incubation Centre (BIIC) of Mahatma Gandhi University, has earned national recognition for its approach to combating antimicrobial resistance (AMR). The company's proposal was selected by the Centre for Cellular and Molecular Platforms (C-CAMP) in the AMR challenge as one of nine solutions from nearly 200 submissions across India. Vividew's solution focusses on eliminating antibiotics and antibiotic-resistant bacteria from hospital wastewater. It employs an integrated treatment process combining advanced oxidation, membrane filtration, biological treatment, and thermal processing. The system is noted for being cost-effective, scalable and well-suited for implementation in healthcare environments.

Business Standard

3 days ago

• Business Standard

Pharma manufacturing tends to cause AMR in communities: Nick Voulvoulis

Changes are required both in manufacturing practices as well as in regulatory oversight, says Voulvoulis Sohini Das Mumbai Listen to This Article Nick Voulvoulis is professor of environmental technology at the Centre for Environmental Policy, Imperial College, London. He has collaborated with Indian institutions for research that uncovered the link between antibiotic manufacturing in the country and the rise of antimicrobial resistance (AMR). Voulvoulis, in an email interview with Sohini Das, explained how low-cost antibiotics pressure manufacturers to spend on costly waste disposal. Edited excerpts: Which AMR research projects are you working on? I led a project called AMRWatch, which was one of five funded projects under the India-UK Tackling AMR in the Environment from Antimicrobial Manufacturing Waste programme funded by the

The Hindu

3 days ago

• The Hindu

SCIINV Biosciences inks pact with UK- based Microbira Ltd

SCIINV Biosciences, a Hyderabad-based biotech startup incubated at ASPIRE BioNEST, University of Hyderabad (UoH), has announced a strategic partnership with Microbira Ltd, a UK-based biotechnology firm on Wednesday. The collaboration aims to develop and deploy next-generation digital diagnostic solutions to strengthen India's fight against antimicrobial resistance (AMR). 'This initiative is a crucial step in curbing inappropriate antibiotic use through timely pathogen detection. Such targeted interventions are fundamental in our fight against drug resistance,' said Prof. Pallu Reddanna, senior professor (retd.), School of Life Sciences. Infectious diseases specialist Ranga Reddy Burri said combating AMR requires affordable, accessible, and reliable diagnostics. CEO of Microbira Ltd, Marianne Ismail, CEO of ASPIRE BioNEST Anil Konda Reddy and SCIINV Biosciences Krishna Burri were also present, said a press release.